baber/WOPTO huggingface dataset:
Patent NZ-571392-A (NZ)
Title: Anchor bolt with internal hardenable substance and mixing element
Inventor: BAYERL MICHAEL
IPC: E21D20/00
Filed: 2008-09-19
Abstract: A fastening element 11 with an anchor tube 12 that has a holding space 13 for a hardenable substance, and with a boring head 21 at one end of the anchor tube, wherein the boring head 21 has at least one entry opening 23 open towards the holding space 13 and at least one outward open passing-through 24 opening for the hardenable substance, wherein a mixing element 31 for the hardenable substance is provided in the boring head 21 between the at least one entry opening 23 and the at least one passing-through 24 opening.
Patent NZ-579355-A (NZ)
Title: 2-(Aryl)-4-oxo-quinazoline derivatives
Inventor: HANSEN HENRIK
IPC: A61K31/4375
Filed: 2007-02-01
Abstract: Disclosed are 2-(aryl)-4-oxo-quinazoline derivatives as represented by the general formula (II), wherein: X is N; R1 and R3 are each independently selected from alkoxy and hydrogen; R2 is selected from alkoxy, alkyl, and hydrogen; R6 and R8 are each independently selected from alkyl, alkoxy, chloride, and hydrogen; R5 is hydrogen; R7 is selected from amino, hydroxyl, alkoxy, and alkyl substituted with a heterocyclyl, or two adjacent substituents selected from R6, R7, and R8 are connected to form a heterocyclyl; R4 is hydrogen or is absent; each W is independently selected from C and N, wherein if W is N, then p is 0 or 1, and if W is C, then p is 1; with the proviso that if R2 is selected from alkoxy or hydrogen, then at least one of R1 and R3 is alkoxy; with the proviso that if R7 is selected from hydroxyl or alkoxy, then at least one of R6 and R8 are independently selected from alkyl, alkoxy, and chloride; with the proviso that if for W-(R7)p, W is N and p is 0, then at least one of R6 and R8 is chloride; and pharmaceutically acceptable salts and hydrates thereof. Representative compounds include 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one. Further disclosed is a pharmaceutical composition which comprises a compound as defined above and a pharmaceutically acceptable carrier for treating or preventing a cardiovascular cholesterol or lipid related disorder in a mammal, and particularly where said disorder is atherosclerosis.
Patent NZ-579660-A (NZ)
Title: System for distributing updates throughout a wireless network of microcontroller devices such as meters
Inventor: RICHESON KEITH D
IPC: H04W8/24
Filed: 2008-04-16
Abstract: Disclosed is a wireless network (120) of microcontroller devices (114) which receive memory updates wirelessly. The network (120) comprises a control node (116) and a plurality of device nodes (114a, 114b) in communication with the control node (116). Each of the device nodes (114a, 114b) has a wireless communication path to the control node (116) that is either a direct path or an indirect path through one or more intermediate device nodes (114a) which serve as relays. Each device node (114a, 114b) has a corresponding device comprising an embedded microcontroller with a flash memory. The device nodes (114a, 114b) comprise broadcast nodes (114a) that are configured to receive a microcontroller flash memory update via a broadcast transmission and non-broadcast nodes (114b) that are not configured to receive updates via a broadcast transmission. The control node (116) transmits a microcontroller flash memory update to the plurality of broadcast nodes (114a) over the wireless network (120). The update is first transmitted to broadcast nodes (114a) with direct communication paths to the control node (116). The update is then relayed to by one or more of the broadcast nodes (114a) to other broadcast nodes until it has been transmitted to each broadcast node (114a) in the network (120). The control node (116) determines when all of the broadcast nodes (114a) have received the update and, based on this determination, sends a command to transmit the update from one or more broadcast nodes (114a) to each non-broadcast node (114b).
Patent NZ-581372-A (NZ)
Title: Anti tnf alpha receptor type one polypeptides, antibody variable domains and antagonists
Inventor: JESPERS LAURENT
IPC: C07K16/00
Filed: 2008-06-04
Abstract: Disclosed is an anti-TNFa receptor type 1 (TNFR1; p55) immunoglobulin single variable domain comprising an amino acid sequence that is at least 99 % identical to the amino acid sequence of DOM1h-131-206 (shown in figure 3). Also disclosed is the use of the TNFa receptor type 1 antagonist in the manufacture of a medicament for treating and/or prophylaxis of an inflammatory condition.
Patent NZ-587747-A (NZ)
Title: Combination of 1-[(methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(piperidin-1-yl)-xanthine (BI-1356), metformin and a stabilising agent
Inventor: FRIEDL THOMAS
IPC: C07D211/56
Filed: 2009-04-02
Abstract: Disclosed is a pharmaceutical composition which comprises or is made from a DPP-IV inhibitor which is 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine free base (BI-1356), a partner drug which is metformin hydrochloride, one or more pharmaceutical excipients, and a nucleophilic and/or basic agent and/or buffering agent (such as L-arginine, L-lysine and L-histidine) for stabilizing said DPP-4 inhibitor against degradation. Further disclosed is a solid pharmaceutical composition (such as a mono-layer tablet, a bi-layer tablet, a press-coated tablet or a film-coated tablet) comprising or made from 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine, metformin hydrochloride, L-arginine, and one or more fillers, one or more binders, one or more glidants and/or one or more lubricants.
Patent NZ-589582-A (NZ)
Title: Method and Apparatus For Honey Measurement
Inventor: AITKENHEAD CATHERINE
IPC: A23L21/25
Filed: 2010-11-29
Abstract: Disclosed is a method for determining the concentration values of key constituent chemicals of honey in the manufacture of a honey composition, comprising the steps of: (a) estimating the botanical origin of at least one standard honey sample, by: (i) obtaining key constituent chemical concentrations; and (ii) assigning the botanical origin as a numerical value on the basis of abundance of chemical compounds characteristic of certain botanical groups; (b) generating the fluorescence signature of standard honey samples, by: (i) exciting a diluted honey sample solution with light of wavelengths at increasing increments over the range 200-700nm; and (ii) measuring the intensity of the fluorescent light emitted from the excited solution with light of wavelengths at increasing increments over the range 280-650nm; and (iii) measuring the wavelength of the fluorescent light emitted from the excited solution with light of wavelengths at increasing increments over the range 280-650nm; and (iv) combining excitation and emitted light as 2-dimensional excitation-emission matrix (EEM); (c) constructing a validated predictive mathematical model from standard honey data, by: (i) using the botanical origin value determined in step (a) as the first matrix in a multivariate analysis; (ii) using the fluorescence EEM data determined in step (b) as the second matrix in a multivariate analysis; (iii) generating a mathematical model using these two matrices; and, (iv) establishing a statistical confidence of predictive power of mathematical model with leave-one-out validation process; (d) generate the fluorescence EEM signature of an unknown honey sample or samples, as outlined in step (b); and (e) using the unknown honey fluorescence EEM data from step (d) with the validated mathematical model of step (c) to predict and assign concentration values of key constituent chemicals of honey with defined statistical confidence.
Patent NZ-590359-A (NZ)
Title: Pyrazine compounds for inflammation and immune-related uses
Inventor: SUN LIJUN
IPC: C07D401/00
Filed: 2006-01-25
Abstract: Disclosed herein is a pyrimidine compound of general formula (XIV) wherein X8 and X9 are N and X10 and X11 are CH or CZ; or X10 and X11 are N and X8 and X9 are CH or CZ; X6 is CH or N; and the substituents are as defined within the specification, processes for their preparation and compositions comprising said compounds. Particularly preferred compounds include N-[2-(2-Chloro-5- trifluoromethyl-phenyl)-pyrimidin-5-yl]-2,6-difluorobenzamide; N-[5-(2-Chloro-5- trifluoromethyl-phenyl)-pyrimidin-2-yl]-2,6-difluorobenzamide. Such compounds are useful in the manufacture of a medicament for inhibiting immune cell activation; inhibiting cytokine production in a cell; inhibiting T-cell and/or B-cell proliferation in response to an antigen; the treatment and/or prevention of immune disorders; and for suppressing the immune system.
Patent NZ-594921-A (NZ)
Title: Customer retention system
Inventor: RAGUNATHAN REVATHI
IPC: G06Q30/00
Filed: 2011-08-31
Abstract: A customer retention system and a method for customer retention using the computing system are disclosed. The system comprises processor; and a memory coupled to the processor. The memory comprises a tagging module, an analysis module and an interaction module. The tagging module is executable by the processor and configured to receive a customer profile object corresponding to a target customer from a Customer Relationship Management (CRM) system, in response to a customer profile request and tag a customer profile object to an associated profile type from among a plurality of predefined profile types stored in profile data. The customer profile object comprises a plurality of profile parameters of the target customer and the tag is based at least in part on the plurality of profile parameters. Each of the plurality of predefined profile types is categorized based on respective plurality of profile parameters. The analysis module is executable by the processor and configured to select, based on the associated profile type, one or more retention policies corresponding to the associated profile type from a plurality of retention policies stored in retention policy data. Each of the one or more retention policies is associated with a weightage indicative of number of acceptances by different target customers and each of the one or more retention policies is classified as one of a preferred policy and a non-preferred policy based on the weightage. The analysis module is further configured to provide the one or more retention policies to a user device communicatively coupled to the system, for providing to the target customer; receive, from the user device, an input regarding at least one retention policy classified as preferred policy from among the one or more retention policies. The input indicates whether a, target customer has accepted or rejected the at least one retention policy. The analysis module is further configured to calculate an updated weightage of the at least one retention policy for the associated profile type based on the input from the user device. The interaction module is executable by the processor and configured to update at least one of the plurality of parameter in the customer profile object of the target customer in the profile data based on the input from the user device for updating the CRM system. The analysis module is further configured to re-classify the at least one retention policy as one of the preferred policy and the non-preferred policy for the associated profile type based on the updated weightage for providing to a next target customer with the associated profile type.
Patent NZ-596583-A (NZ)
Title: Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
Inventor: THEDE KAI
IPC: A61K31/41
Filed: 2007-10-12
Abstract: Disclosed herein are dihydropyrazolone compounds of formula I, wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Such compounds are useful in the treatment and or prophylaxis of cardiovascular diseases, cardiac insufficiency, anemia, chronic kidney diseases and renal insufficiency.
Patent NZ-616960-A (NZ)
Title: Prenylated hydroxystilbenes
Inventor: DUKE COLIN CHARLES
IPC: C07C39/205
Filed: 2012-05-04
Abstract: Disclosed are prenylated hydroxystilbene compounds of formula I where the substituents are as defined herein. Also disclosed are methods of synthesis of the compounds and the use of the compounds in the manufacture of medicaments for the treatment of cancer, immunosuppression, inflammation, bacterial or fungal infection and skin aging.
Patent NZ-626459-A (NZ)
Title: Method and apparatus for intra mode coding
Inventor: GUO MEI
IPC: H04N19/50
Filed: 2012-12-28
Abstract: Disclosed are method and apparatus for predictive Intra coding of a block. The method comprises determining a set of Intra prediction modes and applying predictive Intra coding to a PU (prediction unit) of an image based on one or more neighbouring PUs according a current Intra prediction mode. The current Intra prediction mode is selected from the set of Intra prediction modes. The set of Intra prediction modes is used for PUs corresponding to different block sizes including a 4x4 block size and at least one other block size.
Patent NZ-631269-A (NZ)
Title: Pluggable time signal adapter modules for selecting a time reference interface
Inventor: WILSON STUART
IPC: G06F15/16
Filed: 2014-09-11
Abstract: Disclosed is a network server comprising a motherboard with a processor, a memory, a plurality of sockets and a plurality of network co-processing cards coupled to the plurality of sockets of the motherboard. Each of the plurality of network co-processing cards has a coprocessor, a plurality of small form-factor pluggable (SFP) data ports in communication with the co-processor and a time signal port in communication with the coprocessor. The network server also has a plurality of SFP time signal adapter modules coupled into each time signal port of each of the plurality of network co-processing cards to receive a time reference signal. The time signal adapter modules can receive reference time signals according to different protocols. A method for constructing such a network server is also disclosed, as well as an SFP time signal adaptor module.
Patent NZ-704660-A (NZ)
Title: Process for making isoquinoline compounds
Inventor: THOMPSON MICHAEL D
IPC: C07D217/26
Filed: 2013-07-15
Abstract: The present invention relates to methods for making isoquinoline compounds and the intermediate compounds achieved thereby. Such compounds can be used to prepare compounds and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
Patent NZ-709183-A (NZ)
Title: A coating composition
Inventor: WITT-SANSON CHRISTELLE
IPC: C09D179/08
Filed: 2013-12-18
Abstract: The invention relates to a coating composition comprising a resin material comprising a polyester imide polymer; one or more titanate material; one or more OH reactive cross linking material; and one or more acidic polyester material. The coating composition is particularly suitable for coating of metal substrates, such as for coating aerosol cans.
Patent NZ-713932-A (NZ)
Title: Electric apparatus, air conditioner, external controller, mobile terminal, and air conditioning system
Inventor: NAGAMINE MOTOI
IPC: G08C17/02
Filed: 2014-08-08
Abstract: The object is to obtain an electric apparatus capable of immediately using an application program at the time of installing an apparatus without causing pressure on the capacity of a storage region included in a controller of the apparatus to be controlled while reducing loads on an external server and a communication line. Also, the electric apparatus is capable of making each apparatus perform a specific function by a mobile terminal to be operated. An electric apparatus (for example, air conditioner 10) which is remotely operated by an operation unit included in a mobile terminal 16 includes an application data storing unit (for example, application data storage region) for storing specific data of the electric apparatus. The operation unit includes a common operation unit having a communication driver and a screen configuration frame common to the same kind of electric apparatuses and a specific operation unit having information specific for the electric apparatus.
Patent NZ-714292-A (NZ)
Title: HIGHLY CONCENTRATED FORMULATIONS OF SOLUBLE Fc RECEPTORS
Inventor: POHL THOMAS
IPC: A61K38/17
Filed: 2014-04-16
Abstract: The invention relates to novel high concentration formulations of human soluble FcγRIIB comprising NaCl and either a citrate or histidien buffer at specific pH. The invention further relates to the use of such formulations as pharmaceutical compositions for the treatment of autoimmune diseases, infections and other conditions where the immune system is involved.
Patent NZ-720090-A (NZ)
Title: Climbing test bench for scooters
Inventor: YAO JIN
IPC: G01M17/007
Filed: 2016-05-12
Abstract: The present invention discloses a climbing test bench for scooters, comprising a middle bridge arranged horizontally and above the ground and a first skew bridge and a second skew bridge which are arranged at both ends of the middle bridge; an upper end of the first skew bridge is hinged with one end of the middle bridge, an upper end of the second skew bridge is hinged with the other end of the middle bridge, a lower end of the first skew bridge and a lower end of the second skew bridge are in contact with the ground, respectively; and a lifting device is arranged below the middle bridge, and the lifting device may drive the middle bridge to rise and fall so that the first skew bridge and the second skew bridge form different tilt angles. Due to light weight of a scooter, it is not desired to provide a truss-frame structure. The arrangement of a lifting device can ensure the stability of the present invention. An inspector can control the rise and fall of the middle bridge by the lifting device to enable the first skew bridge and the second skew bridge on front and back sides of the middle bridge to form different tilt angles, so as to make it possible to perform different climbing tests on scooters at different angles.
Patent NZ-721717-A (NZ)
Title: Personal vehicle, and control apparatus and control method therefore
Inventor: Juhász Márton 
IPC: A61G5/04
Filed: 2014-12-05
Abstract: The invention is a control apparatus for a personal vehicle, in particular for wheelchair (10), the control apparatus comprising - a first motion sensing unit (11) adapted for being mounted on a body part and for determining orientation with respect to an external frame of reference, - a second motion sensing unit (12) adapted for being mounted on the personal vehicle and for determining orientation with respect to the same external frame of reference, and - a processing unit (13) adapted for outputting an inertial control signal corresponding to a relative orientation of the first motion sensing unit (11) and of the second motion sensing unit (12) determined on the basis of a first orientation supplied by the first motion sensing unit (11) and of a second orientation supplied by the second motion sensing unit (12). The invention is furthermore a personal vehicle provided with the control apparatus, and a control method therefore.
Patent NZ-734127-A (NZ)
Title: System and method for a man-portable mobile ad-hoc radio based linked extensible network
Inventor: MAZZARELLA JOSEPH R
IPC: H04W76/00
Filed: 2016-02-04
Abstract: Embodiments include a system, method, and computer program product for a mobile ad-hoc radio based linked extensible (MARBLE) unit that is a portable, self-contained mesh-capable radio transceiver unit capable of being deployed with other MARBLE units to form a local area ad hoc mesh network. Several MARBLE units may be distributed in the field by an operator (e.g., first responder) in the form of a ball, puck or other shaped enclosure that may be held by a human hand and thrown, tossed or placed in the field to deploy a local area ad hoc mesh network. The MARBLE units may exchange information among themselves to determine and select one MARBLE unit as a relay gateway to access an IP network for all of the MARBLE units coupled to the local area ad hoc mesh network. The system also comprises one or more camera sensors and a light emitting diode (LED) material, wherein one or more processors are configured to receive an image data from a first camera sensor of the one or more camera sensors based on a first local vicinity; interpret at least one of a color, a pattern, or a brightness of the image data; create an exterior image file using a three-dimensional shape of the portable system and the interpreted image data; and transmit the exterior image file to the LED material, wherein the LED material presents an exterior image to a corresponding portion of the exterior of the portable system.
Patent NZ-739328-A (NZ)
Title: Managing functions on an ios mobile device using ancs notifications
Inventor: BREAUX JOSEPH
IPC: G06F3/02
Filed: 2016-06-23
Abstract: Systems, methods, and devices for managing predetermined functions on a mobile device (150) within a moving vehicle (110), the mobile device having an operating system (OS) that includes an event API installed therein that is configured for two-way communication with an external control device (75), the control device being installed within the vehicle and further configured to communicate with a software application installed and running in memory resident on the mobile device. In response to initiation of a predetermined function on the mobile device, a notification message is transmitted by the event API to the control device. The control device then communicates with the software application to determine a desired action for the mobile device to take with respect to the predetermined function. The control device then instructs the mobile device on the action to take on the predetermined function by transmitting an action message to the event API.
Patent NZ-757940-A (NZ)
Title: Bag web and method and equipment for packing items
Inventor: PAPE HENRIK
IPC: B65B9/08
Filed: 2018-03-27
Abstract: Bag web (1), equipment (7) and method for packing items, liquid or bulk goods in film bags, which are conveyed in a continuous bag web (1) of bag items (2) through a filling station (9). The mouths of the bags are held open for receiving items, after which the bags are closed and are separated from the web. The bag web (1) comprises a zip closure (4), which is applied parallel to the upper edge of the bag web (1) and is continuous for the entire length of the bag web. The zip closure (4) is coupled to the first guiding means (8), which are arranged to retain and guide the bag web (1) in the zip closure (4) along a first section of a transport web through the equipment (7). The filling station comprises bag opening means (15), which force the edges of the bag mouth apart for successive opening of the bags in the filling station (9). The mouths of the bags are brought back together after the filling station (9) in that the bag web (1) is coupled to second guiding means (11) for retaining and guiding the bag web (1) in the zip closure (4) along another section of the transport web through the equipment. Then closure and sealing of the mouths of the bags are also carried out along the upper non-sealed part of the lateral edges of the bag items. There is reduced wastage of material, with quick and easy filling of bag items (2).
Patent NZ-758196-A (NZ)
Title: A laminate membrane, an implant comprising the laminate membrane and a method of manufacturing the same
Inventor: WALL SEAN
IPC: B32B25/00
Filed: 2018-05-18
Abstract: An embolization device comprising a core with a laminated membrane and flexible bristles extending from it, where the membrane comprises an inner layer of PUR and PTFE composite and covering layers of a hydrophilic material on both sides and has contracted delivery and expanded delivery configuration. This minimizes deformation of the membrane during translation through the delivery catheter, whilst also allowing reliable expansion of the membrane and adjacent bristles to their expanded deployed configurations.